High-throughput quantification of tissue microarrays: Identification of candidate target proteins in inflammatorv breast cancer;La lecture automatisée à haut débit des micro-biopsies en pathologie: Mise en évidence de la surexpression de c-Met et PI3K dans les cancers du sein inflammatoire

Bulletin de l'Academie Nationale de Medecine

Volumn 191, Issue 2, 2007, Pages 361-376

  Taranger Charpin, Colette ^d   Andrac Meyer, Lucile ^a   Dales, Jean Philippe ^d   Carpentier Meunier, Séverine ^a   Andonian, Claudine ^a   Lavaut, Marie Noelle ^a   Allasia, Claude ^b   Bonnier, Pascal ^c  

^a HÔPITAL NORD   (France)

^b AIX MARSEILLE UNIVERSITY   (France)

^c HÔPITAL DE LA CONCEPTION   (France)

^d NONE

Author keywords

Biopsy; Densitometry; Immunohistochemistry; Proto oncogene proteins c Met

Indexed keywords

CADHERIN; FOCAL ADHESION KINASE 1; PTK2 PROTEIN, HUMAN; SCATTER FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ADENOCARCINOMA; ADULT; BIOPSY; BREAST; BREAST TUMOR; COMPARATIVE STUDY; DENSITOMETRY; FEMALE; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; METABOLISM; MORTALITY; PATHOLOGY; PHENOTYPE; REVIEW; TISSUE MICROARRAY;

ADENOCARCINOMA; ADULT; BIOPSY; BREAST; BREAST NEOPLASMS; CADHERINS; DENSITOMETRY; FEMALE; FOCAL ADHESION KINASE 1; HUMANS; IMMUNOHISTOCHEMISTRY; PHENOTYPE; PROTO-ONCOGENE PROTEINS C-MET; TISSUE ARRAY ANALYSIS;

EID: 38449115576     PISSN: 00014079     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0001-4079(19)33081-x     Document Type: Article

References (38)

1. JAIYESIMI I.A., BULZDAR A.U., HORTOBAGYI G. - Inflammatory breast cancer : A review. J. Clin. Oncol, 1992, 10, 1014-1024.
2. BUZDAR A.U., SINGLETARY S.E., BOOSER D.J. et al. - Combined modality treatment of stage III and inflammatory breast cancer. M.D. Anderson Cancer Center experience. Surg. Oncol. Clin. N. Am., 1995, 4, 715-734.
3. TAVASSOLI F. and DEVILEE P.- WHO classification of Tumours. Tumours of breast and female genital organs. IARC Press, Lyon, 2001, 47-49.
4. [4] BERTUCCI F., FINETTI P., ROUGEMONT J., CHARAFE-JAUFFRET E., NASSER V., LORIOD B., CAMERLO J., TAGETT R., TARPIIN C., HOUVENAEGHEL G., NGUYEN C., MARANINCHI D., JACQUEMIER J., HOULGATTE R., BIRNBAUM D., VIENS P. - Gene expression profiling for molecular characterization of inflammatory breast cancer and prediction of response to chemotherapy. Cancer Res., 2004, 64, 8558-8565. (Pubitemid 39552068)
5. CHARAFE-JAUFFRET E., TARPIN C., BARDOU V.J., BERTUCCI F., GINESTIER C., BRAUD A.C., PUIG B., GENEIX J., HASSOUN J., BIRNBAUM D., JACQUEMIER J. et D. VIENS P. -Immunophenotypic analysis of inflammatory breast cancers : Identification of an " inflammatory signature ". J. Path., 2004, 202, 265-273.
6. [6] GASPARINI G., LONGO R., FANELLI M., TEICHER B.A. - Combination of antiangiogenic therapy with other anticancer therapies : Results, challenges and open questions. J. Clin. Oncol., 2005, 23, 1295-1311. (Pubitemid 46202288)
7. [7] PENNACCHIETTI S., MICHIELI P., GALLUZZO M., MAZZONE M., GIORDANO S., COMOGLIO P.M. - Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene. Cancer Cell., 2003, 3, 347-361. (Pubitemid 38340304)
8. BIRCHMEIER C., BIRCHMEIER W., GHERARDI E., VANDE WOUDE G.F.- Met, metastasis, motility and more. Nat. Rev. MoI. Cell. Biol, 2003, 4, 915-925.
9. [9] CHRISTENSEN J.G., BURROWS J., SALGIA R. - C-met as a target for human cancer and characterization of inhibitors for therapeutic intervention. Cancer Letters, 2005, 225, 1-26. (Pubitemid 40732764)
10. [10] BEVIGLIA L., MATSUMOTO K., LIN C.S., ZIOBER B.L., KRAMER R.H. - Expression of the c-met/HGF receptor in human breast carcinoma : Correlation with tumour progression. Int. J. Cancer, 1997, 74, 301-309. (Pubitemid 27321800)
11. [11] GHOUSSOUB R.A., DILLON D.A., D'AQUILA T.G., RIMM E.B., FEARON E.R., RIMM D.L. - Expression of c-met is a strong independent prognostic factor in breast carcinoma. Cancer, 1998, 52, 1513-1520. (Pubitemid 28164998)
12. [12] TOLGAY OCAL I., DOLLED-FILHART M., D'AQUILA T.G., CAMP R.L., RIMM D.L. - Tissue microarray-based studies of patients with lymph node negative breast carcinoma show that met expression is associated with worse outcome but is not correlated with epidermal growth factor family receptors. Cancer, 2003, 97, 1841-1848. (Pubitemid 36397257)
13. [13] CAMP R.L., RIMM E.B., RIMM D.L. - Met expression is associated with poor outcome in patients with axillary lymph node negative breast carcinoma. Cancer, 1999, 86, 2259-2265. (Pubitemid 30010366)
14. [14] NAKIPOULOU L., GAKIOPOULOU H., KERAMOPOULOS A., GIANNOPOULOU L., ATHANASSIADOU P., MAVROMMATIS J., DAVARiS P.S. - C-met tyrosine kinase receptor expression is associated with abnormal beta-catenin expression and unfavourable prognostic factors in invasive breast carcinoma. Histopathol., 2000, 36, 313-325. (Pubitemid 30198913)
15. [15] LEE W. Y., CHEN H.H., CHOW N.H., Su W.C., LIN P.W., Guo H.R.- Prognostic significance of co-expression of Ron and Met receptors in node-negative breast cancer patients. Clin. Cancer Res., 2005, 11, 2222-2228. (Pubitemid 40490180)
16. [16] MAULIK G., SHRIKHANDE A., KIJIMA T., MA P.C., MORRISON P.T., SALGIA R. - Role of the hepatocyte growth factor receptor, c-met, in oncogenesis and potential for therapeutic inhibition. Cytokine Growth Factor Rev., 2002, 13, 41-59. (Pubitemid 34436961)
17. [17] MA P.C., MAULIK G., CHRISTENSEN J., SALGIA R. - C-met : Structure, functions and potential for therapeutic inhibition. Cancer Meta. Rev., 2003, 22, 309-325. (Pubitemid 36791889)
18. [18] TRUSOLINO L., COMOGLIO P.M. - Scatter-Factor and Semaphorin receptors : Cell signaling for invasive growth. Nature, 2002, 2, 289-300. (Pubitemid 37328782)
19. [19] KALLIONIEMI O.P., WAGNER U., KONONEN J., SAUTER G. - Tissue microarray technology for high-throughput molecular profiling of cancer. Hum. MoI. Genet., 2001, 10, 657-662. (Pubitemid 32331572)
20. [20] CHARPIN C., DALÈS J.P., GARCIA S., CARPENTIER S., DJEMLI A., ANDRAC L., LAVAUT M.N., ALLASIA C., BONNIER P. - Tumour neoangiogenesis by CD31 and CD 105 expression evaluation in breast carcinoma tissue microarrays. Clin. Cancer Res., 2004, 10, 5815-5819. (Pubitemid 39180960)
21. GINESTIER C., CHARAFE-JAUFFRET E., BERTUCCI F., EISINGER J., GENEIX L, BECHLIAN D., CONTE N., ADELAÏDE J., TOIRON Y., NGUYEN C., VBHNS P., MOZZICONACCI M.J., HOULGATTE R., BIRNBAUM D., JACQUEMIER J. - Distinct and complentary information provided by use of tissue and DNA microarrays in the study of breast tumour markers. Am. J. Pathol., 2002, 161, 1223-1233.
22. [22] DALÈS J.P., GARCIA S., MEUNIER-CARPENTIER S., ANDRAC-MEYER L., HADDAD O., LAVAUT M.N., ALLASIA C., BONNIER P., CHARPIN C. - Overexpression of hypoxia-inducible factor HIF-1α predicts early relapse in breast cancer : Retrospective study in a series of 745 patients. Int. J Cancer, 2005, 116, 734-739. (Pubitemid 41099705)
23. [23] DALÈS J.P., GARCIA S., CARPENTIER S., ANDRAC L., RAMUZ O., LAVAUT M.N., ALLASIA C., BONNIER P., CHARPIN C. - Long-term prognostic significance of neoangiogenesis in breast carcinomas : Comparison of Tie-2/Tek, CD105 and CD31 immunocytochemical expression. Human Path, 2004, 35, 176-183. (Pubitemid 38240899)
24. [24] CHARPIN C., GARCIA S., BONNIER P., MARTINI F., ANDRAC L., CHOUX R., LAVAUT M.N., ALLASIA C. - Reduced E-cadherin immunohistochemical expression in node-negative breast carcinomas correlates with 10-year survival. Am. J. Clin. Pathol., 1998, 109, 431-438. (Pubitemid 28151031)
25. 23/NDPK automated and quantitative immunocytochemical assays in breast carcinomas. J. Pathol., 1998, 184, 401-407.
26. [26] CHARPIN C., GARCIA S., BOUVœR C., BONNIER P., MARTINI F., ANDRAC L., HORSCHOWSKI N., LAVAUT M.N., ALLASIA C. - Bcl-2 automated and quantitative immunocytochemical assays in breast carcinoma : correlation with 10 year follow-up. J. Clin. Oncol., 1998, 16, 2025-2031. (Pubitemid 28265036)
27. [27] CHARPIN C., GARCIA S., BOUVIER C., MARTINI F., ANDRAC L., BONNIER P., LAVAUT M.N., ALLASIA C - CD31 /PECAM automated and quantitative immunocytochemical assays in breast carcinomas. Correlation with patient follow-up. Am. J. Clin. Pathol., 1997, 107, 534-541. (Pubitemid 27183985)
28. [28] CHARPIN C., VIELH P., DUFFAUD F., DEVICTOR B., ANDRAC L., LAVAUT M.N., ALLASIA C., HORSCHOWSKI N., PIANA L. - Quantitative immunocytochemical assays of P-glycoprotein in breast carcinomas : Correlation to mRNA expression and to immunohistochemical prognostic indicators. J Nat Cane Inst, 1994, 20, 1539-1545. (Pubitemid 24330219)
29. [29] CHARPIN C., GARCIA S., BOUVIER C., DEVICTOR B., ANDRAC L., CHOUX R., LAVAUT M.N., ALLASIA C. - Automated and quantitative immunocytochemical assays of CD44v6 in breast carcinomas. Hum. Pathol., 1997, 28, 289-296. (Pubitemid 27106080)
30. [30] LAID A.D., CHERRINGTON J.M. - Small molecule tyrosine kinase inhibitors : Clinical development of anticancer agents. Expert Opin. Investig. Drugs, 2003, 72, 51-64. (Pubitemid 36104643)
31. [31] MATSUMOTO K., NAKAMURA T. - NK4 (HGF-antagonist/angiogenesis inhibitor) in cancer biology and therapeutics. Cancer Sci., 2003, 94, 321-327. (Pubitemid 36626362)
32. ZHENG Z., ADAMS C., MOFFAT B., SCHWALL R.A. CHIMERIC - Fab. Antibody serves as an antagonist to the HGF/SF receptor c-met. Proc. Am. Assoc. Cancer Res., 2003, 43, 5717.
33. MORTON P.A., JOY W.D., BONO C.P., ARBUCKLE A., EVANS M.L., HUYNH M.S.-In vitro and in vivo activity of fully-human monoclonal antibody antagonists to c-met protein tyrosine kinase. Proc. Am. Assoc. Cancer Res., 2003, 43, 5604.
34. SCHWALL R., ADAMS W.D., ZHENG Z., ROMERO M., MAI E., MOFFAT B.- Inhibition of c-met activation by a one-armed antibody. Proc. Am. Assoc. Cancer Res., 2004, 44, 1424.
35. [35] CHRISTENSEN J.G., SCHRECK R., BURROWS J., KURUGANTI P., CHAN E. - Le P. A selective small molecule inhibitor of c-met kinase inhibits c-met-dependent phenotypes in vitro and exhibits cytoreductive antitumour activity in vivo. Cancer Res., 2003, 63, 7345-7355. (Pubitemid 37413476)
36. WANG X., LE P., LIANG C., CHAN J., KIENLICH D., MILLER T.- Potent and selective inhibitors of the Met [hepatocyte growth factor/scatter factor (HGF/SF) receptor] tyrosine kinase block HGF/SF-induced tumour cell growth and invasion. Mol. Cancer Ther., 2003, 2, 1085-1092.
37. [37] CAMP R.L., CHUNG G.C., RIMM D.L. - Automated subcellular localization and quantification of protein expression in tissue microarrays. Nature Med., 2002, 8, 1323-1327. (Pubitemid 35373567)
38. PAGES F., BERGER A., CAMUS M., SANCHEZ-CABO F., COSTES A., MOLIDOR R., MLECNIK B., KIRILOSKY A., NILSSON M., DAMOTTE D., MEATCGI T., BRUNEVAL P., CUGNENC P.H., TRAJANOSKI Z., FRIDMAN W.H., GALON J. - Effector Memory T Cells, early metastasis and survival in colorectal cancer. N. Engl. J. Med., 2006, 25, 2654-2666.